Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Metabolic Brain Disease|December 1, 2001
The central opioid system in liver disease and its complicationsC YurdaydinAlcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1993
The role of endogenous benzodiazepines in hepatic encephalopathy: animal studiesE A Jones, C Yurdaydin, A S BasileActa Paediatrica Japonica : Overseas Edition|January 20, 1999
Hereditary pancreatitis: report of a family from TurkeyA Kansu, N Girgin, C Yurdaydin, et al.Advances in Experimental Medicine and Biology|January 1, 1993
Do benzodiazepine ligands contribute to hepatic encephalopathy?E A Jones, A S Basile, C Yurdaydin, et al.Journal of Hepatology|December 2, 1999
Combination treatment of hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure in the rat with benzodiazepine and opioid receptor antagonistsT Celik, T Uzbay, K Cinar, et al.European Journal of Gastroenterology & Hepatology|July 1, 1996
Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonistsC Yurdaydin, A M Herneth, A Püspök, et al.Mikrobiyoloji Bulteni|October 1, 1990
[Parasite prevalence in schools with different socioeconomic status and evaluation of methods for diagnosing intestinal parasitic diseases]M K Balci, S Aydoğdu, O Koç, et al.Journal of Hepatology|December 2, 1998
Opioid receptor ligands in human hepatic encephalopathyC Yurdaydin, D Karavelioglu, O Onaran, et al.Archives of Virology|January 25, 2007
Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell linesH Kayhan, E Karatayli, A R Turkyilmaz, et al.Human & Experimental Toxicology|December 22, 1999
Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of ratsA Akbay, K Cinar, O Uzunalimoğlu, et al.Pageof 4